<!--
title: Amantadine Treatment for People with COVID-19
description: DOI: 10.1016/j.arcmed.2020.06.009
published: true
date: 2022-01-07T21:57:42.804Z
tags: #sarscov2, #covid, #treatment, #efficiacy, #amantadine, #prevention, #medication
editor: ckeditor
dateCreated: 2022-01-07T21:57:40.490Z
-->

<p>Arch Med Res</p>
<p>. 2020 Oct;51(7):739-740.</p>
<p>doi: 10.1016/j.arcmed.2020.06.009. Epub 2020 Jun 12.</p>
<h1><strong>Amantadine Treatment for People with COVID-19</strong></h1>
<p><a href="https://pubmed.ncbi.nlm.nih.gov/?term=Ara%C3%BAjo+R&amp;cauthor_id=32571606">Ramiro Araújo</a><sup>&nbsp;</sup><a href="https://pubmed.ncbi.nlm.nih.gov/32571606/#affiliation-1"><sup>1</sup></a>,&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/?term=Aranda-Mart%C3%ADnez+JD&amp;cauthor_id=32571606">José Dolores Aranda-Martínez</a><sup>&nbsp;</sup><a href="https://pubmed.ncbi.nlm.nih.gov/32571606/#affiliation-2"><sup>2</sup></a>,&nbsp;<a href="https://pubmed.ncbi.nlm.nih.gov/?term=Aranda-Abreu+GE&amp;cauthor_id=32571606">Gonzalo Emiliano Aranda-Abreu</a><sup>&nbsp;</sup><a href="https://pubmed.ncbi.nlm.nih.gov/32571606/#affiliation-3"><sup>3</sup></a></p>
<p>Affiliations expand</p>
<ul>
  <li>PMID: <strong>32571606</strong></li>
  <li>PMCID: <a href="http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7290190/">PMC7290190</a></li>
  <li>DOI: <a href="https://doi.org/10.1016/j.arcmed.2020.06.009">10.1016/j.arcmed.2020.06.009</a></li>
</ul>
<p><strong>Free PMC article</strong></p>
<h2><strong>Abstract</strong></h2>
<p>SARS-Cov-2, whose symptoms include difficulty swallowing, coughing, diarrhea, and breathing failure, has caused the loss of many lives around the world. In the absence of a vaccine or medication to help prevent or decrease the effects of the disease, we suggest that amantadine may reduce the effects of COVID-19.</p>
<p>&nbsp;</p>
<p>https://pubmed.ncbi.nlm.nih.gov/32571606/</p>
